His primary areas of investigation include Genetics, Huntington's disease, Alzheimer's disease, Genome-wide association study and Locus. His work in Allele, Linkage disequilibrium and Gene are all subfields of Genetics research. His work in the fields of Huntington's disease, such as Huntingtin and Huntingtin Protein, overlaps with other areas such as Law and economics.
Lesley Jones usually deals with Alzheimer's disease and limits it to topics linked to Apolipoprotein E and Genetic association. His Genome-wide association study study is related to the wider topic of Single-nucleotide polymorphism. His Single-nucleotide polymorphism research includes themes of Disease and Age of onset.
Genetics, Huntington's disease, Disease, Gene and Huntingtin are his primary areas of study. His Single-nucleotide polymorphism, Genome-wide association study, Allele, Locus and Genetic association study are his primary interests in Genetics. Apolipoprotein E and Case-control study is closely connected to Alzheimer's disease in his research, which is encompassed under the umbrella topic of Genome-wide association study.
His Huntington's disease research is multidisciplinary, relying on both Phenotype, Neuroscience, Neurodegeneration and Trinucleotide repeat expansion. Lesley Jones studied Disease and Psychiatry that intersect with Cognitive decline. His Huntingtin study combines topics in areas such as Molecular biology and Cell biology.
Lesley Jones mainly focuses on Huntington's disease, Genetics, Trinucleotide repeat expansion, Disease and Gene. His Huntington's disease study incorporates themes from Irritability, Depression and Locus. His study in Genome-wide association study, MSH3, Allele, Genetic association and Single-nucleotide polymorphism falls within the category of Genetics.
His Genome-wide association study research is multidisciplinary, incorporating elements of Dementia and Pathogenesis. The study incorporates disciplines such as Meta-analysis, Lipid metabolism and Alzheimer's disease in addition to Genetic association. His work deals with themes such as Psychiatry, Psychosis and Oncology, which intersect with Disease.
Lesley Jones mostly deals with Genetics, Huntington's disease, Trinucleotide repeat expansion, Gene and Locus. In his study, which falls under the umbrella issue of Genetics, Pathogenesis is strongly linked to Disease. His research in Huntington's disease intersects with topics in Allele and Exon.
His research investigates the link between Trinucleotide repeat expansion and topics such as MSH3 that cross with problems in Somatic cell, MLH3, Polyglutamine tract, Genotype and Candidate gene. His study looks at the relationship between Locus and topics such as Human genetics, which overlap with Cognitive decline, Medical genetics, Gene mapping, Haplotype and Human genome. His Genome-wide association study research entails a greater understanding of Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Huntington's disease
Gillian Bates;K P S J Murphy;P Harper;L Jones.
Oxford University Press (2002)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Regional and cellular gene expression changes in human Huntington's disease brain.
Angela Kaye Hodges;Andrew D. Strand;Aaron K. Aragaki;Alexandre Kuhn.
Human Molecular Genetics (2006)
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold.
PLOS ONE (2010)
The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.
Amy N. Packer;Yi Xing;Scott Q. Harper;Lesley Jones.
The Journal of Neuroscience (2008)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
Susceptibility Locus for Alzheimer's Disease on Chromosome 10
Amanda Myers;Peter Holmans;Helen Marshall;Jennifer Kwon.
Science (2000)
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
Jong-Min Lee;Vanessa C. Wheeler;Michael J. Chao;Jean Paul G. Vonsattel.
Cell (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cardiff University
Cardiff University
Cardiff University
Cardiff University
Cardiff University
University of Oxford
Harvard University
University College London
Icahn School of Medicine at Mount Sinai
Harvard University
Hong Kong Polytechnic University
Deakin University
University of Girona
University of Washington
Stanford University
University of Foggia
Aligarh Muslim University
Carnegie Institution for Science
Bournemouth University
University of New South Wales
Leibniz Association
University of Sydney
National Institutes of Health
Washington University in St. Louis
Oregon Health & Science University
Netherlands Institute for Social Research